Color-coded fluorescent protein imaging of angiogenesis: The AngioMouse® models

Current Pharmaceutical Design

Volumn 14, Issue 36, 2008, Pages 3810-3819

  Amoh, Yasuyuki ^a   Katsuoka, Kensei ^a   Hoffman, Robert M ^b,c  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ANTICANCER INC   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Green fluorescent protein; Human tumors; Imaging; Nascent blood vessels; Nude mouse; Red fluorescent protein

Indexed keywords

DOXORUBICIN; GEMCITABINE; GREEN FLUORESCENT PROTEIN; IRINOTECAN; NESTIN; RED FLUORESCENT PROTEIN; INTERMEDIATE FILAMENT PROTEIN; NERVE PROTEIN;

ANGIOGENESIS; BREAST CANCER; CARCINOGENESIS; CELL PROLIFERATION; DISEASE MODEL; FLUORESCENCE IMAGING; HAIR FOLLICLE; HOST RESISTANCE; HUMAN; IMAGE DISPLAY; IMAGE QUALITY; LIVER METASTASIS; NONHUMAN; PANCREAS CANCER; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKIN FLAP; TRANSGENE; TUMOR; TUMOR GROWTH; WHOLE BODY IMAGING; ANIMAL; ANIMAL MODEL; EXPERIMENTAL NEOPLASM; GENETICS; HAIR; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; STEM CELL; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALS; GREEN FLUORESCENT PROTEINS; HAIR; INTERMEDIATE FILAMENT PROTEINS; MICE; MICE, NUDE; MICE, TRANSGENIC; MODELS, ANIMAL; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; STEM CELLS;

EID: 61449106917     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208786898644     Document Type: Review

References (58)

1. Auerbach R, Kubai L, Knighton D, Folkman J. A simple procedure for the long-term cultivation of chicken embryos. Dev Biol 1974; 41: 391-4.
2. Crum R, Szabo S, Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 1985; 230: 1375-8.
3. Miller JW, Stinson WG, Folkman J. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology 1993; 100: 9-14.
4. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 1992; 67: 519-28.
5. Alessandri G, Raju K, Gullino PM. Mobilization of capillary endothelium in vitro induced by effectors of angiogenesis in vivo. Cancer Res 1983; 43: 1790-7.
6. Deutsch TA, Hughes WF. Sfr4 tuppressive effects of indomethacin on thermally induced neovascularization of rabbit corneas. Am J Ophthalmol 1979; 87: 536-40.
7. Korey M, Peyman GA, Berkowitz R. The effect of hypertonic ointments on corneal alkali burns. Ann Ophthalmol 1977; 9: 1383-7.
8. Mahoney J M, Waterbury LD. Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea. Curr Eye Res 1985; 4: 531-5.
9. Li WW, Grayson G, Folkman J, D'Amore PA. Sustained-release endotoxin. A model for inducing corneal neovascularization. Invest Ophthalmol Vis Sci 1991; 32: 2906-11.
10. Epstein RJ, Hendricks RL, Stulting RD. Interleukin-2 induces corneal neovascularization in A/J mice. Cornea 1990; 9: 318-23.
11. Gimbrone MA Jr, Cotran RS, Leapman SB, Folkman J. Tumor growth and neovascularization: An experimental model using the rabbit cornea. J Natl Cancer Inst 1974; 52: 413-27.
12. Fournier GA, Lutty GA, Watt S, Fenselau A, Patz A. A corneal micropocket assay for angiogenesis in the rat eye. Invest Ophthalmol Vis Sci 1981; 21: 351-4.
13. Muthukkaruppan V, Auerbach R. Angiogenesis in the mouse cornea. Science 1979; 205: 1416-8.
14. Papenfuss HD, GrossJF, Intaglietta M, Treese FA. A transparent access chamber for the rat dorsal skin fold. Microvasc Res 1979; 18: 311-8.
15. Shan S, Robson ND, Cai Y, Qiao T, Li CY, Kontos CD, et al. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival. FASEB J 2004; 18: 326-8.
16. Dewhirst M, Gross J, Sim D, Arnold P, Boyer D. The effect of rate of heating or cooling prior to heating on tumor and normal tissue microcirculatory blood flow. Biorheology 1984; 21: 539-58.
17. Fukumura D, Xavier R, Sugiura T, Chen Y, Park EC, Lu N, et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 1998; 94: 715-25.
18. Li CY, Shan S, Huang Q, Braun R D, Lanzen J, Hu K, et al. Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models. J Natl Cancer Inst 2000; 92: 143-7.
19. Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: A new model for metastasis. Nat Med 2000; 6: 100-2.
20. Huang Q, Shan S, Braun RD, Lanzen J, Anyrhambatla G, Kong G, et al. Noninvasive visualization of tumors in rodent dorsal skin window chambers. Nat Biotechnol 1999; 17: 1033-5.
21. Cowen,SE, Bibby MC, Double JA. Characterisation of the vasculature within a murine adenocarcinoma growing in different sites to evaluate the potential of vascular therapies. Acta Oncol 1995; 34: 357-60.
22. Prasher DC, Eckenrode VK, Ward WW, Prendergast FG, Cormier MJ. Primary structure of the Aequorea victoria green-fluorescent protein. Gene 1992; 111: 229-33.
23. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC. Green fluorescent protein as a marker for gene expression. Science 1994; 263: 802-5.
24. Cheng L, Fu J, Tsukamoto A, Hawley RG. Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nat Biotechnol 1996; 14: 606-9.
25. Cody CW, Prasher DC, Westler WM, Prendergast FG, Ward WW. Chemical structure of the hexapeptide chromophore of the Aequorea green fluorescent protein. Biochemistry 1993; 32: 1212-8.
26. Yang F, Moss LG, Phillips GN Jr. The molecular structure of green fluorescent protein. Nat Biotechnol 1996; 14: 1246-51.
27. Morin J, Hastings J. Energy transfer in a bioluminescent system. J Cell Physiol 1971; 77: 313-8.
28. Cormack B, Valdivia R, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 1996; 173: 33-8.
29. Crameri A, Whitehorn EA, Tate E, Stemmer WP. Improved green fluorescent protein by molecular evolution using DNA shuffling. Nat Biotechnol 1996; 14: 315-9.
30. Delagrave S, Hawtin RE, Silva CM, Yang MM, Youvan DC. Redshifted excitation mutants of the green fluorescent protein. Biotechnology 1995; 13: 151-4.
31. Heim R, Cubitt AB, Tsien RY. Improved green fluorescence. Nature 1995; 373: 663-4.
32. Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka N. A 'humanized' green fluorescent protein cDNA adapted for highlevel expression in mammalian cells. J Virol 1996; 70: 4646-54.
33. Gross LA, Baird GS, Hoffman RC, Baldridge KK, Tsien RY. The structure of the chromophore within DsRed, a red fluorescent protein from coral. Proc Natl Acad Sci USA 2000; 97: 11990-5.
34. Fradkov AF, Chen Y, Ding L, Barsova EV, Matz MV, Lukyanov SA. Novel fluorescent protein from Discosoma coral and its mutants possesses a unique far-red fluorescence. FEBS Lett 2000; 479: 127-30.
35. Chishima T, Miyagi Y, Wang X, Yamaoka H, Shimada H, Moossa AR, et al. Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res 1997; 57: 2042-7.
36. Yang M, Baranov E, Jiang P, Sun FX, Li XM, Hasegawa S, et al. Whole-body optical imaging of green fluorescent proteinexpressing tumors and metastases. Proc Natl Acad Sci USA 2000; 97: 1206-11.
37. Hoffman RM. Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Lancet Oncol 2002; 3: 546-56.
38. Hoffman RM. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic. Invest New Drugs 1999; 17: 343-59.
39. Yang M, Baranov E, Li XM, Wang JW, Jiang P, Li L, et al. Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors. Proc Natl Acad Sci USA 2001; 98: 2616-21.
40. Yang M, Baranov E, Wang JW, Jiang P, Wang X., Sun FX, et al. Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model. Proc Natl Acad Sci USA 2002; 99: 3824-9.
41. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 1997; 407: 313-9.
42. Yang M, Li L, Jiang P, Moossa AR, Penman S, Hoffman RM. Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc Natl Acad Sci USA 2003; 100: 14259-62.
43. Amoh Y, Li L, Yang M, Moossa AR, Katsuoka K, Penman S, et al. Nascent blood vessels in the skin arise from nestin-expressing hair follicle cells. Proc Natl Acad Sci USA 2004; 101: 13291-5.
44. Amoh Y, Li L, Yang M, Jiang P, Moossa AR, Katsuoka K, et al. Hair follicle-derived blood vessels vascularize tumors in skin and are inhibited by doxorubicin. Cancer Res 2005; 65: 2337-43.
45. Amoh Y, Yang M, Li L, Reynoso J, Bouvet M, Moossa AR, et al. Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis. Cancer Res 2005; 65: 5352-7.
46. Amoh Y, Li L, Tsuji K, Moossa AR, Katsuoka K, Hoffman RM, et al. Dual-color imaging of nascent blood vessels vascularizing pancreatic cancer in an orthotopic model demonstrates antiangiogenesis efficacy of gemcitabine. J Surgical Research 2006; 132: 164-9.
47. Amoh Y, Nagakura C, Maitra A, Moossa AR, Katsuoka K, Hoffman RM, et al. Dual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer. Anticancer Res 2006; 26: 3237-42.
48. Amoh Y, Bouvet M, Li L, Tsuji K, Moossa AR, Katsuoka K, et al. Visualization of nascent tumor angiogenesis in lung and liver metastasis by differential dual-color fluorescence imaging in nestinlinked-GFP mice. Clin Exp Metastasis 2006; 23(7-8): 315-22.
49. Ji Y, Hayashi K, Amoh Y, Tsuji K, Yamauchi K, Yamamoto N, et al. The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer. Anticancer Res 2007; 27: 713-8.
50. Hayashi K, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Amoh Y, et al. Dual-color imaging of angiogenesis and its inhibition in bone and soft tissue sarcoma. J Surg Res 2007; 140: 165-70.
51. Hayashi K, Jiang P, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, et al. Real-time imaging of tumor-cell shedding and trafficking in lymphatic channels. Cancer Res 2007; 67: 8223-8.
52. McElroy M, Hayashi K, Garmy-Susini B, Kaushal S, Varner JA, Moossa AR, et al. Imaging with fluorescent LYVE-1 to visualize lymphatic trafficking of cancer. J Surg Res 2008; In press.
53. Mecklenburg L, Tobin DJ, Muller-Rover S, Handjiski B, Wendt G, Peters EM, et al. Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol 2000; 114: 909-16.
54. Yano K, Brown LF, Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest 2001; 107: 409-17.
55. Bodo E, Tobin DJ, Kamenisch Y, Biro T, Berneburg M, et al. Dissecting the impact of chemotherapy on the human hair follicle: A pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy. Am J Pathol 1007; 17: 1153-67.
56. Amoh Y, Li L, Katsuoka K, Hoffman RM. Chemotherapy targets the hair-follicle vascular network but not the stem cells. J Invest Dermatol 2007; 127: 11-5
57. Amoh Y, Li L, Katsuoka K, Bouvet M, Hoffman RM. GFPexpressing vascularization of Gelfoam® as a rapid in vivo assay of angiogenesis stimulators and inhibitors. Biotechniques 2007; 42: 294-8.
58. Shaked Y, Ciarrocchi A, Franco M, Lee CR, Man S, Cheung AM, et al. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006; 313(5794): 1785-7.